You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
皓元醫藥(688131.SH):正籌劃收購藥源藥物100%股權 2月21日起停牌
格隆匯 02-18 22:07

格隆匯2月18日丨皓元醫藥(688131.SH)公佈,公司正在籌劃發行股份及支付現金購買資產並募集配套資金事項。公司擬通過發行股份及支付現金的方式向WANG YUAN(王元)上海源盟企業管理諮詢合夥企業(有限合夥)、啟東源力企業管理諮詢合夥企業(有限合夥)寧波九勝創新醫藥科技有限公司收購其持有的藥源藥物化學(上海)有限公司(藥源藥物)100%股權同時擬向公司控股股東上海安戌信息科技有限公司發行股份募集配套資金不超過5000萬元

根據初步測算,此次交易預計不構成《上市公司重大資產重組管理辦法》、《科創板上市公司重大資產重組特別規定》等規定的重大資產重組,不會導致公司實際控制人發生變更。鑑於此次交易擬向公司控股股東上海安戌信息科技有限公司發行股份募集配套資金,此次交易構成關聯交易。

根據上海證券交易所的相關規定,經公司申請,公司股票2022221開市起開始停預計停牌時間不超過10個交易日。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account